www.fdanews.com/articles/152315-adma-biologics-executes-long-term-manufacturing-supply-and-license-agreements-with-biotest
ADMA Biologics Executes Long-Term Manufacturing, Supply and License Agreements With Biotest
January 11, 2013
ADMA Biologic announced it has entered into a long-term manufacturing, supply and license agreement with Biotest Pharmaceuticals and a license agreement with Biotest AG, BPC’s parent company.
BusinessWire
BusinessWire